TP53 and cancer: Down-regulation of viral HPV E6 and E7 represents a viable strategy to induce functional p53 for cervical cancer therapies, which would in turn further induce downstream target genes involved in cell circle arrest and apoptosis and thus restore growth control in tumor cells or sensitize cells to cancer therapies [34].